Sphingosine 1-phosphate and inflammation
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
AbstractSphingosine 1-phosphate (S1P), a sphingolipid mediator, regulates various cellular functions via high-affinity G protein-coupled receptors, S1P1-5. The S1P-S1P receptor signaling system plays important roles in lymphocyte trafficking and maintenance of vascular integrity, thus contributing to the regulation of complex inflammatory processes. S1P is enriched in blood and lymph while maintained low in intracellular or interstitial fluids, creating a steep S1P gradient that is utilized to facilitate efficient egress of lymphocytes from lymphoid organs. Blockage of the S1P-S1P receptor signaling system results in a marked decrease in circulating lymphocytes because of a failure of lymphocyte egress from lymphoid organs. This provides a basis of immunomodulatory drugs targeting S1P1 receptor such as FTY720, an immunosuppressive drug approved in 2010 as the first oral treatment for relapsing–remitting multiple sclerosis. The S1P-S1P receptor signaling system also plays important roles in maintenance of vascular integrity since it suppresses sprouting angiogenesis and regulates vascular permeability. Dysfunction of the S1P-S1P receptor signaling system results in various vascular defects, such as exaggerated angiogenesis in developing retina and augmented inflammation due to increased permeability. Endothelial-specific deletion of S1P1 receptor in mice fed high-fat diet leads to increased formation of atherosclerotic lesions. This review highlights the importance of the S1P-S1P receptor signaling system in inflammatory processes. We also describe our recent findings regarding a specific S1P chaperone, apolipoprotein M, that anchors to high-density lipoprotein and contributes to shaping the endothelial-protective and anti-inflammatory properties of high-density lipoprotein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Kappos, L., Radue, E.-W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,644
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149
Self-citationAn Overview of Sphingolipid Metabolism: From Synthesis to Breakdown
Gault, C. R., Obeid, L. M., & Hannun, Y. A. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6741-1_1 · Cited by 1,071
Lee, M.-J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., & Hla, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81661-x · Cited by 1,013
Self-citationMultiple Sclerosis: Current Knowledge and Future Outlook
Kamm, C. P., Uitdehaag, B. M., & Polman, C. H. (2014) · European Neurology · doi:10.1159/000360528 · Cited by 1,010
Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate
Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., et al. (2009) · Science · doi:10.1126/science.1176709 · Cited by 997
Garcia, J. G. N., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., & English, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12450 · Cited by 886
Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., et al. (2010) · Nature · doi:10.1038/nature09128 · Cited by 752
Essential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742
Massberg, S., Schaerli, P., Knezevic-Maramica, I., Köllnberger, M., Tubo, N., Moseman, E. A., Huff, I. V., Junt, T., Wagers, A. J., Mazo, I. B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.047 · Cited by 696
Finding a way out: lymphocyte egress from lymphoid organs
Schwab, S. R., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1545 · Cited by 605
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
Christoffersen, C., Obinata, H., Kumaraswamy, S. B., Galvani, S., Ahnström, J., Sevvana, M., Egerer-Sieber, C., Muller, Y. A., Hla, T., Nielsen, L. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103187108 · Cited by 598
Self-citationChiba, K., Yanagawa, Y., Masubuchi, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M., & Hoshino, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.5037 · Cited by 596
Dynamics of endothelial cell behavior in sprouting angiogenesis
Eilken, H. M., & Adams, R. H. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.010 · Cited by 561
FUJITA, T., INOUE, K., YAMAMOTO, S., IKUMOTO, T., SASAKI, S., TOYAMA, R., CHIBA, K., HOSHINO, Y., & OKUMOTO, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.208 · Cited by 540
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
Venkataraman, K., Lee, Y.-M., Michaud, J., Thangada, S., Ai, Y., Bonkovsky, H. L., Parikh, N. S., Habrukowich, C., & Hla, T. (2008) · Circulation Research · doi:10.1161/circresaha.107.165845 · Cited by 482
Self-citationNatural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
Walzer, T., Chiossone, L., Chaix, J., Calver, A., Carozzo, C., Garrigue-Antar, L., Jacques, Y., Baratin, M., Tomasello, E., & Vivier, E. (2007) · Nature Immunology · doi:10.1038/ni1523 · Cited by 431
Kono, M., Mi, Y., Liu, Y., Sasaki, T., Allende, M. L., Wu, Y.-P., Yamashita, T., & Proia, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403937200 · Cited by 415
Murata, N., Sato, K., Kon, J., Tomura, H., YANAGITA, M., Kuwabara, A., Ui, M., & Okajima, F. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520809 · Cited by 407
Oo, M. L., Thangada, S., Wu, M.-T., Liu, C. H., Macdonald, T. L., Lynch, K. R., Lin, C.-Y., & Hla, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610318200 · Cited by 405
Self-citationThe Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors
Kawahara, A., Nishi, T., Hisano, Y., Fukui, H., Yamaguchi, A., & Mochizuki, N. (2009) · Science · doi:10.1126/science.1167449 · Cited by 405
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation
Allende, M. L., Yamashita, T., & Proia, R. L. (2003) · Blood · doi:10.1182/blood-2003-02-0460 · Cited by 380
Sanchez, T., Estrada-Hernandez, T., Paik, J.-H., Wu, M.-T., Venkataraman, K., Brinkmann, V., Claffey, K., & Hla, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306896200 · Cited by 374
Self-citationCamerer, E., Regard, J. B., Cornelissen, I., Srinivasan, Y., Duong, D. N., Palmer, D., Pham, T. H., Wong, J. S., Pappu, R., & Coughlin, S. R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38575 · Cited by 367
T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow
Jenne, C. N., Enders, A., Rivera, R., Watson, S. R., Bankovich, A. J., Pereira, J. P., Xu, Y., Roots, C. M., Beilke, J. N., Banerjee, A., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090525 · Cited by 334
Chun, J., Hla, T., Lynch, K. R., Spiegel, S., & Moolenaar, W. H. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003111 · Cited by 330
Self-citationFlow-Regulated Endothelial S1P Receptor-1 Signaling Sustains Vascular Development
Jung, B., Obinata, H., Galvani, S., Mendelson, K., Ding, B.-S., Skoura, A., Kinzel, B., Brinkmann, V., Rafii, S., Evans, T., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.07.015 · Cited by 317
Self-citationGaengel, K., Niaudet, C., Hagikura, K., Laviña, B., Muhl, L., Hofmann, J. J., Ebarasi, L., Nyström, S., Rymo, S., Chen, L. L., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.005 · Cited by 317
Galvani, S., Sanson, M., Blaho, V. A., Swendeman, S. L., Obinata, H., Conger, H., Dahlbäck, B., Kono, M., Proia, R. L., Smith, J. D., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2581 · Cited by 314
Self-citationAdachi, K., Kohara, T., Nakao, N., Arita, M., Chiba, K., Mishina, T., Sasaki, S., & Fujita, T. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00127-f · Cited by 304
Green, J. A., Suzuki, K., Cho, B., Willison, L. D., Palmer, D., Allen, C. D. C., Schmidt, T. H., Xu, Y., Proia, R. L., Coughlin, S. R., et al. (2011) · Nature Immunology · doi:10.1038/ni.2047 · Cited by 280
Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization
Paik, J.-H., Skoura, A., Chae, S.-S., Cowan, A. E., Han, D. K., Proia, R. L., & Hla, T. (2004) · Genes & Development · doi:10.1101/gad.1227804 · Cited by 278
Self-citationIs it time to revise the HDL cholesterol hypothesis?
Rader, D. J., & Tall, A. R. (2012) · Nature Medicine · doi:10.1038/nm.2937 · Cited by 272
Ishii, I., Friedman, B., Ye, X., Kawamura, S., McGiffert, C., Contos, J. J. A., Kingsbury, M. A., Zhang, G., Brown, J. H., & Chun, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104441200 · Cited by 272
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
Zemann, B., Kinzel, B., Müller, M., Reuschel, R., Mechtcheriakova, D., Urtz, N., Bornancin, F., Baumruker, T., & Billich, A. (2006) · Blood · doi:10.1182/blood-2005-07-2628 · Cited by 264
Kimura, T., Sato, K., Kuwabara, A., Tomura, H., Ishiwara, M., Kobayashi, I., Ui, M., & Okajima, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104353200 · Cited by 261
Yanagawa, Y., Sugahara, K., Kataoka, H., Kawaguchi, T., Masubuchi, Y., & Chiba, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5493 · Cited by 260
Ishii, I., Ye, X., Friedman, B., Kawamura, S., Contos, J. J. A., Kingsbury, M. A., Yang, A. H., Zhang, G., Brown, J. H., & Chun, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200137200 · Cited by 244
Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets
Vu, T. M., Ishizu, A.-N., Foo, J. C., Toh, X. R., Zhang, F., Whee, D. M., Torta, F., Cazenave-Gassiot, A., Matsumura, T., Kim, S., et al. (2017) · Nature · doi:10.1038/nature24053 · Cited by 237
HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
Blaho, V. A., Galvani, S., Engelbrecht, E., Liu, C., Swendeman, S. L., Kono, M., Proia, R. L., Steinman, L., Han, M. H., & Hla, T. (2015) · Nature · doi:10.1038/nature14462 · Cited by 227
Self-citationYanagida, K., Liu, C. H., Faraco, G., Galvani, S., Smith, H. K., Burg, N., Anrather, J., Sanchez, T., Iadecola, C., & Hla, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618659114 · Cited by 212
Self-citationCardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications
Camm, J., Hla, T., Bakshi, R., & Brinkmann, V. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.06.028 · Cited by 210
Self-citationSphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720
Kharel, Y., Lee, S., Snyder, A. H., Sheasley-O'Neill, S. L., Morris, M. A., Setiady, Y., Zhu, R., Zigler, M. A., Burcin, T. L., Ley, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506293200 · Cited by 210
Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells
Hisano, Y., Kobayashi, N., Yamaguchi, A., & Nishi, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038941 · Cited by 209
Fingolimod-associated macular edema: Incidence, detection, and management
Jain, N., & Bhatti, M. T. (2012) · Neurology · doi:10.1212/wnl.0b013e318248deea · Cited by 202
Sphingosine-1-Phosphate Mediates Migration of Mature Dendritic Cells
Czeloth, N., Bernhardt, G., Hofmann, F., Genth, H., & Förster, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2960 · Cited by 195
Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice
Kono, M., Belyantseva, I. A., Skoura, A., Frolenkov, G. I., Starost, M. F., Dreier, J. L., Lidington, D., Bolz, S.-S., Friedman, T. B., Hla, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700370200 · Cited by 191
Self-citationSphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
Sattler, K. J. E., Elbasan, Ş., Keul, P., Elter-Schulz, M., Bode, C., Gräler, M. H., Bröcker-Preuss, M., Budde, T., Erbel, R., Heusch, G., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0112-5 · Cited by 191
The vascular S1P gradient—Cellular sources and biological significance
HLA, T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.07.003 · Cited by 180
Self-citationLack of sphingosine 1-phosphate-degrading enzymes in erythrocytes
Ito, K., Anada, Y., Tani, M., Ikeda, M., Sano, T., Kihara, A., & Igarashi, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.123 · Cited by 178
Ligand-induced Trafficking of the Sphingosine-1-phosphate Receptor EDG-1
Liu, C. H., Thangada, S., Lee, M.-J., Van Brocklyn, J. R., Spiegel, S., & Hla, T. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.1179 · Cited by 178
Self-citationSphingosine 1-phosphate in coagulation and inflammation
Obinata, H., & Hla, T. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0287-3 · Cited by 174
Self-citationNakahara, K., Ohkuni, A., Kitamura, T., Abe, K., Naganuma, T., Ohno, Y., Zoeller, R. A., & Kihara, A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.033 · Cited by 174
Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier
Wilkerson, B. A., Grass, G. D., Wing, S. B., Argraves, W. S., & Argraves, K. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423426 · Cited by 173
Thangada, S., Khanna, K. M., Blaho, V. A., Oo, M. L., Im, D.-S., Guo, C., Lefrancois, L., & Hla, T. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091343 · Cited by 172
Self-citationThe Transporter Spns2 Is Required for Secretion of Lymph but Not Plasma Sphingosine-1-Phosphate
Mendoza, A., Bréart, B., Ramos-Perez, W. D., Pitt, L. A., Gobert, M., Sunkara, M., Lafaille, J. J., Morris, A. J., & Schwab, S. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.021 · Cited by 167
Argraves, K. M., Sethi, A. A., Gazzolo, P. J., Wilkerson, B. A., Remaley, A. T., Tybjærg‐Hansen, A., Nordestgaard, B. G., Yeatts, S. D., Nicholas, K. S., Barth, J. L., et al. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-70 · Cited by 130
Sattler, K., Gräler, M. H., Keul, P., Weske, S., Reimann, C., Jindrová, H., Kleinbongard, P., Sabbadini, R. A., Bröcker‐Preuß, M., Erbel, R., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.057 · Cited by 120
An engineered S1P chaperone attenuates hypertension and ischemic injury
Swendeman, S. L., Xiong, Y., Cantalupo, A., Yuan, H., Burg, N. D., Hisano, Y., Cartier, A., Liu, C. H., Engelbrecht, E., Blaho, V. A., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal2722 · Cited by 115
Self-citationChristensen, P. M., Liu, C. H., Swendeman, S. L., Obinata, H., Qvortrup, K., Nielsen, L. B., Hla, T., Lorenzo, A. D., & Christoffersen, C. (2016) · The FASEB Journal · doi:10.1096/fj.201500064 · Cited by 114
Self-citationVascular and immunobiology of the circulatory sphingosine 1-phosphate gradient
Yanagida, K., & Hla, T. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071635 · Cited by 109
Self-citationThe Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease
Brewer, H. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0163 · Cited by 102
Lipid phosphate phosphatases and lipid phosphate signalling
Pyne, S., Long, J. S., Ktistakis, N. T., & Pyne, N. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331370 · Cited by 97
Christoffersen, C., Ahnström, J., Axler, O., Christensen, E., Dahlbäck, B., & Nielsen, L. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800695200 · Cited by 75
Igarashi, Y., & Yatomi, Y. (1998) · Acta Biochimica Polonica · doi:10.18388/abp.1998_4226 · Cited by 72
Keul, P., Polzin, A., Kaiser, K., Gräler, M. H., Dannenberg, L., Daum, G., Heusch, G., & Levkau, B. (2018) · The FASEB Journal · doi:10.1096/fj.201801245r · Cited by 64
Watkins, M. T. (2010) · Yearbook of Vascular Surgery · doi:10.1016/s0749-4041(10)79323-4 · Cited by 58
The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality
Prüfer, N., Kleuser, B., & van der Giet, M. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0192 · Cited by 40
Tong, X., Lv, P., Mathew, A. V., Liu, D., Niu, C., Wang, Y., Liang, J., Li, J., Fu, Z., Pan, B., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-82 · Cited by 33
Zhang, H., Pluháčková, K., Jiang, Z., & Böckmann, R. A. (2016) · Scientific Reports · doi:10.1038/srep30655 · Cited by 26
Cited by
Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance
Kojta, I., Chacińska, M., & Błachnio-Zabielska, A. (2020) · Nutrients · doi:10.3390/nu12051305 · Cited by 526
Morris, G., Puri, B. K., Bortolasci, C. C., Carvalho, A., Berk, M., Walder, K., Moreira, E. G., & Maes, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.037 · Cited by 84
Metadata
- Authors
- Obinata, H., & Hla, T.
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-11
- Volume
- 31
- Issue
- 9
- Pages
- 617-625
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2936762825
- Cited by
- 268
- References
- 76
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.